[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100287569":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":17,"responsibleParty":34,"collaborators":7,"id":37,"slug":38,"hasResults":39,"nctId":40,"briefTitle":41,"officialTitle":41,"acronym":7,"eligibilityCriteria":42,"healthyVolunteers":39,"sex":43,"minAge":7,"maxAge":7,"enrollmentInfo":44,"targetDuration":47,"studyType":48,"phases":7,"briefSummary":49,"conditions":50,"keywords":52,"overallStatus":19,"whyStopped":7,"lastUpdateSubmitDate":54,"lastUpdatePostDateStruct":55,"startDateStruct":57,"completionDateStruct":59,"leadSponsor":61,"locationsCount":62},{"fullName":5,"class":6},"Peking Union Medical College Hospital","OTHER",null,[9,14],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Yunyun Fei","CONTACT","+8613681125226","feiyunyun2013@hotmail.com",{"name":15,"role":11,"phone":7,"phoneExt":7,"email":16},"Wen Zhang","zhangwen91@sina.com",[18],{"facility":5,"status":19,"city":20,"state":21,"zip":22,"country":23,"countryCode":24,"cosmosGeoPoint":25,"geoPoint":30,"contacts":31},"RECRUITING","Beijing","Beijing Municipality","100032","China","CN",{"type":26,"coordinates":27},"Point",[28,29],116.39723,39.9075,{"lat":29,"lon":28},[32,33],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},{"name":15,"role":11,"phone":7,"phoneExt":7,"email":16},{"type":35,"investigatorFullName":15,"investigatorTitle":36,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Professor","100287569","national-registry-of-igg4-rd-in-china-100287569",false,"NCT03023371","National Registry of IgG4-RD in China","Inclusion Criteria:\n\n* Conforming to the diagnostic criteria of IgG4-RD (2011);\n\nExclusion Criteria:\n\n* Excluding other mimicing IgG4-RD, including tumors, vasculitis and sarcoidosis.","ALL",{"count":45,"type":46},900,"ESTIMATED","10 Years","OBSERVATIONAL","The aim of this study is to establish a nation-wide cohort study of IgG4-related disease (IgG4-RD) in China.\n\nMethods: All the patients fulfilling diagnostic criteria of IgG4-RD (2011) would be enrolled from multi-centers around China. A online database system has been established.\n\nEndpoints: The primary endpoint is to investigate the clinical manifestations of Chinese IgG4-RD patients; the secondary endpoints including the demographic features,laboratory characteristics, immunological tests, imaging and pathological features, in addition, the treatment and prognosis of the disease.",[51],"IgG4-Related Disease",[53],"Registry; cohort study; IgG4-related disease","2017-01-23",{"date":56,"type":46},"2017-01-24",{"date":58,"type":7},"2016-12",{"date":60,"type":46},"2026-12",{"name":5,"class":6},1]